drugset / Trial / NCT04094961
Ixazomib + Pomalidomide + Dexamethasone In MM
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I/II study using the combination of twice weekly ixazomib plus pomalidomide and dexamethasone in relapsed and or refractory multiple myeloma (RRMM) patients.
Timeline
- Start
- 2019-09-18
- Primary completion
- 2025-06-01
- Completion
- 2027-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixazomib | Unknown | — | Oral |
| Background | Dexamethasone | Small molecule | — | Oral |
| Background | Pomalidomide | Other / unclassified | — | Oral |